Furey Raymond J.'s most recent trade in Rigel Pharmaceuticals was a trade of 19,497 Common Stock done . Disclosure was reported to the exchange on Feb. 17, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rigel Pharma | Raymond J. Furey | EVP, GC, CCO & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2026 | 19,497 | 51,813 (0%) | 0% | 0 | Common Stock | |
| Rigel Pharma | Raymond J. Furey | EVP, GC, CCO & Corp Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.62 per share. | 10 Feb 2026 | 3,546 | 32,316 (0%) | 0% | 34.6 | 122,763 | Common Stock |
| Rigel Pharma | Raymond J. Furey | EVP, GC, CCO & Corp Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.01 per share. | 02 Feb 2026 | 3,968 | 35,862 (0%) | 0% | 36.0 | 142,888 | Common Stock |
| Rigel Pharma | Raymond J. Furey | EVP, GC, CCO & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2025 | 7,394 | 7,394 | - | - | Employee Stock Option (right to buy) | |
| Rigel Pharma | Raymond J. Furey | EVP, GC, CCO & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 9,375 | 9,375 | - | - | Employee Stock Option (right to buy) | |
| Rigel Pharma | Raymond J. Furey | EVP, GC, CCO & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 7,850 | 7,850 | - | - | Employee Stock Option (right to buy) | |
| Rigel Pharma | Raymond J. Furey | EVP, GC, CCO & Corp Sec | Sale of securities on an exchange or to another person at price $ 20.92 per share. | 04 Feb 2025 | 1,448 | 40,169 (0%) | 0% | 20.9 | 30,294 | Common Stock |
| Rigel Pharma | Raymond J. Furey | EVP, GC, CCO & Corp Sec | Sale of securities on an exchange or to another person at price $ 21.93 per share. | 04 Feb 2025 | 1,339 | 38,830 (0%) | 0% | 21.9 | 29,359 | Common Stock |
| Rigel Pharma | Raymond J. Furey | EVP, GC, CCO & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 19,717 | 41,617 (0%) | 0% | 0 | Common Stock | |
| Rigel Pharma | Raymond J. Furey | EVP, GC, CCO & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 14,788 | 14,788 | - | - | Employee Stock Option (Right to Buy) | |
| Rigel Pharma | Raymond J. Furey | EVP, GC, CCO & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 93,750 | 93,750 | - | - | Employee Stock Option (right to buy) | |
| Rigel Pharma | Raymond J. Furey | EVP, GC, CCO & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 78,500 | 78,500 | - | - | Employee Stock Option (right to buy) | |
| Rigel Pharma | J. Raymond Furey | EVP, GC, CCO & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 209,000 | 214,000 (0%) | 0% | 0 | Common Stock | |
| Rigel Pharma | Furey Raymond J. | EVP, GC, CCO & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 157,000 | 157,000 | - | - | Employee Stock Option (Right to Buy) |